Skip to main content
. 2018 Aug 31;9(68):33030–33042. doi: 10.18632/oncotarget.26050

Figure 2.

Figure 2

CDK1 (A) and CDK2 (B) mRNA expressions in human ACC samples by clinical features. Data from The Cancer Genome Atlas database (n=92). (C) Disease-specific survival in patients with ACC by CDK1 and CDK2 mRNA expression [E-TABM-311 database (n=34)].